Abstract
Protein A affinity chromatography is widely used for capturing therapeutic antibodies. It offers high binding capacity, selectivity, and resin reusability while delivering high yield and product purity. The Protein A step is ubiquitous in its presence in purification platforms for production of antibody products due to the effective clearance it offers of impurities, high and low molecular weight species (HMW and LMW), host cell proteins (HCP), and DNA. In this chapter, we describe a highly selective Protein A affinity chromatography protocol for purification of monoclonal antibodies.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Global Monoclonal Antibody Therapeutics Market Will Reach USD 218.97 Billion by 2023: Zion Market Research, 2018
Shukla AA, Hubbard B, Tressel T, Guhan S, Low D (2007) Downstream processing of monoclonal antibodies—application of platform approaches. J Chromatogr B 848(1):28–39
Bankston TE, Carta G (2010) Apolipoprotein A-IMilano anion exchange chromatography: mass transfer and adsorption kinetics. Biotechnol J 5(10):1040–1049
Hober S, Nord K, Linhult M (2007) Protein a chromatography for antibody purification. J Chromatogr B 848(1):40–47
Schwarz A (2000) Affinity purification of monoclonal antibodies. In: Affinity chromatography. Springer, Berlin, pp 49–56
Kruljec N, Bratkovic T (2017) Alternative affinity ligands for immunoglobulins. Bioconjug Chem 28(8):2009–2030
Shekhawat LK, Godara A, Kumar V, Rathore AS (2018) Design of Experiments Applications in bioprocessing: chromatography process development using Split DOE. Biotechnol Prog 35(1):e2730
Hahn R, Schlegel R, Jungbauer A (2003) Comparison of protein a affinity sorbents. J Chromatogr B 790(1-2):35–51
Ramos-de-la-Peña AM, González-Valdez J, Aguilar O (2019) Protein a chromatography: challenges and progress in the purification of monoclonal antibodies. J Sep Sci 42(9):1816–1827
Kateja N, Agarwal H, Hebbi V, Rathore AS (2017) Integrated continuous processing of proteins expressed as inclusion bodies: GCSF as a case study. Biotechnol Prog 33(4):998–1009
Acknowledgments
Financial assistance from the Department of Biotechnology, Ministry of Science and Technology is gratefully acknowledged (number BT/COE/34/SP15097/2015). We are also thankful to GE Healthcare, Sweden, for providing us some of the consumable items used in this investigation.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Rathore, A.S., Narnaware, S. (2022). Purification of Therapeutic Antibodies by Protein A Affinity Chromatography. In: Houen, G. (eds) Therapeutic Antibodies. Methods in Molecular Biology, vol 2313. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-1450-1_9
Download citation
DOI: https://doi.org/10.1007/978-1-0716-1450-1_9
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-0716-1449-5
Online ISBN: 978-1-0716-1450-1
eBook Packages: Springer Protocols